Coercive Control and Intimate Partner Violence

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorCentre Hospitalier Intercommunal Robert Ballanger

About this trial

Coercive control (CC) is increasingly recognized as a central component of intimate partner violence (IPV) and a major determinant of victims' health outcomes. While widely integrated into policy and legal frameworks in several countries, CC remains insufficiently explored in the French research context, particularly regarding its clinical and psychopathological dimensions. This gap may limit the identification of victims and the provision of appropriate care.

The present study aims to investigate the association between exposure to coercive control and physical and mental health outcomes among victims of intimate partner violence. By improving the understanding of CC-related health impacts, this research seeks to support better identification of high-risk situations and inform clinical and public health interventions.

Eligibility criteria

Qualifiers

Women aged 18 years and older, who have experienced an intimate partner relationship involving violence for at least three months (currently in the relationship or separated).

Women identified as victims of intimate partner violence.

Sufficient proficiency in French to complete self-administered questionnaires and participate in interviews.

No objection to participation in the study (non-opposition).

Disqualifiers

Individuals under legal protection in accordance with the French Public Health Code (Articles L.1121-5 to L.1121-8 and L.1122-1-2), with the exception of pregnant or breastfeeding women.

Cognitive impairment or severe intellectual disability preventing comprehension of the questionnaires.

Severe and unstable psychiatric disorders (e.g., schizophrenia, delusional disorders, acute bipolar disorder).

Trial design

Treatments tested in this trial

  • questionnaire

Treatment groups

250 Participants
are divided into 1 treatment group